Report Detail

Request for Sample of this report

Pharma & Healthcare Global Anti-Peptic Ulcer Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2952625
    • |
  • 15 February, 2019
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.

Scope of the Report:
China’s anti-trust crackdown on foreign pharmaceutical companies has left many foreign investors in the healthcare industry shocked. The Chinese government has had no qualms about openly stating that it prefers hospitals to purchase from domestic producers. That said, China’s homegrown manufacturers of medical devices and medicine still lack the sophistication to produce many of the more advanced health care products the country needs. Amid rising living standards and an aging population, China’s healthcare needs are set to rise sharply in the coming years.
In April 2015, China amended its Drug Administration Law, introducing two major changes.
The first is a simplification of the company set-up procedure for pharmaceutical companies. Prior to the amendment, investors that wanted to manufacture or distribute pharmaceuticals needed to have a Drug Manufacturing License or a Drug Distribution License before applying for a business license. Now, investors may apply for these after the company has been set up, significantly speeding up the incorporation process.

More importantly, the amendment removes the price controls that the Chinese government had in place for medicines. As of the year 2000, medicines that were listed on the government’s Medical Insurance Catalog, and those medicines on which there was a monopoly, had their prices fixed or guided by the government. About 23 percent of the medicines on the Chinese market had government fixed or guided prices. The price of other medicines was left to market forces. While these price restrictions are now fully removed, companies still need to abide by China’s anti-trust laws. Companies abusing their dominant market position are still punishable under Chinese law.
While recent moves have made it easier for foreign investors to introduce new medical products to the Chinese market, the Chinese government has at the same time placed restraints on advertising healthcare products. The final text of the revised Advertising Law was released by the National People’s Congress, China main legislative body, in late April 2015. The law comes into force in September 2015.

The 2015 Advertising Law has special stipulations about advertising for medicine and medical devices. For one, advertising for anesthetics, psychotropic drugs, toxic and radioactive drugs for medical use is not allowed, nor is advertisement for drugs, treatment plans and medical devices to combat drug addiction. Advertising for prescription drugs other than those mentioned previously is only allowed in professional medical journals.

The content for medical advertisements is regulated as well. Any advertisement for drugs, medical treatment or medical devices may not contain the following:

The worldwide market for Anti-Peptic Ulcer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Anti-Peptic Ulcer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs

Market Segment by Applications, can be divided into
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Peptic Ulcer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-Peptic Ulcer Drugs, with price, sales, revenue and global market share of Anti-Peptic Ulcer Drugs in 2017 and 2018.
Chapter 3, the Anti-Peptic Ulcer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Peptic Ulcer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Anti-Peptic Ulcer Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Anti-Peptic Ulcer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Anti-Peptic Ulcer Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Proton Pump Inhibitors (PPIs)
      • 1.2.2 Potassium-Competitive Acid Blockers (P-CAB)
      • 1.2.3 Antacids
      • 1.2.4 H2 Antagonists
      • 1.2.5 Ulcer Protective Drugs
    • 1.3 Market Analysis by Applications
      • 1.3.1 Gastritis
      • 1.3.2 Gastric Ulcers
      • 1.3.3 Duodenal Ulcers
      • 1.3.4 Gastroesophageal Reflux Disease (GERD)
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 AstraZeneca
      • 2.1.1 Business Overview
      • 2.1.2 Anti-Peptic Ulcer Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Ask-pharm
      • 2.2.1 Business Overview
      • 2.2.2 Anti-Peptic Ulcer Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Takeda
      • 2.3.1 Business Overview
      • 2.3.2 Anti-Peptic Ulcer Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Takeda Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Yangtze River Pharm
      • 2.4.1 Business Overview
      • 2.4.2 Anti-Peptic Ulcer Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Shandong Luoxin
      • 2.5.1 Business Overview
      • 2.5.2 Anti-Peptic Ulcer Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Huadong Medicine
      • 2.6.1 Business Overview
      • 2.6.2 Anti-Peptic Ulcer Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Changzhou Siyao
      • 2.7.1 Business Overview
      • 2.7.2 Anti-Peptic Ulcer Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Beijing Yuekang
      • 2.8.1 Business Overview
      • 2.8.2 Anti-Peptic Ulcer Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Guangdong Dahua
      • 2.9.1 Business Overview
      • 2.9.2 Anti-Peptic Ulcer Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Xian Janssen
      • 2.10.1 Business Overview
      • 2.10.2 Anti-Peptic Ulcer Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Anti-Peptic Ulcer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Anti-Peptic Ulcer Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Anti-Peptic Ulcer Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Anti-Peptic Ulcer Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Anti-Peptic Ulcer Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Anti-Peptic Ulcer Drugs Market Analysis by Regions

    • 4.1 Global Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Anti-Peptic Ulcer Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Anti-Peptic Ulcer Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)

    5 North America Anti-Peptic Ulcer Drugs by Country

    • 5.1 North America Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Country
      • 5.1.1 North America Anti-Peptic Ulcer Drugs Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Anti-Peptic Ulcer Drugs Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)

    6 Europe Anti-Peptic Ulcer Drugs by Country

    • 6.1 Europe Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Anti-Peptic Ulcer Drugs Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Anti-Peptic Ulcer Drugs Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Anti-Peptic Ulcer Drugs by Country

    • 7.1 Asia-Pacific Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Anti-Peptic Ulcer Drugs Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Anti-Peptic Ulcer Drugs Revenue and Market Share by Country (2014-2019)
    • 7.2 China Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)

    8 South America Anti-Peptic Ulcer Drugs by Country

    • 8.1 South America Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Country
      • 8.1.1 South America Anti-Peptic Ulcer Drugs Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Anti-Peptic Ulcer Drugs Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Anti-Peptic Ulcer Drugs by Countries

    • 9.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Anti-Peptic Ulcer Drugs Sales and Growth Rate (2014-2019)

    10 Global Anti-Peptic Ulcer Drugs Market Segment by Type

    • 10.1 Global Anti-Peptic Ulcer Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Anti-Peptic Ulcer Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Anti-Peptic Ulcer Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Proton Pump Inhibitors (PPIs) Sales Growth and Price
      • 10.2.1 Global Proton Pump Inhibitors (PPIs) Sales Growth (2014-2019)
      • 10.2.2 Global Proton Pump Inhibitors (PPIs) Price (2014-2019)
    • 10.3 Potassium-Competitive Acid Blockers (P-CAB) Sales Growth and Price
      • 10.3.1 Global Potassium-Competitive Acid Blockers (P-CAB) Sales Growth (2014-2019)
      • 10.3.2 Global Potassium-Competitive Acid Blockers (P-CAB) Price (2014-2019)
    • 10.4 Antacids Sales Growth and Price
      • 10.4.1 Global Antacids Sales Growth (2014-2019)
      • 10.4.2 Global Antacids Price (2014-2019)
    • 10.5 H2 Antagonists Sales Growth and Price
      • 10.5.1 Global H2 Antagonists Sales Growth (2014-2019)
      • 10.5.2 Global H2 Antagonists Price (2014-2019)
    • 10.6 Ulcer Protective Drugs Sales Growth and Price
      • 10.6.1 Global Ulcer Protective Drugs Sales Growth (2014-2019)
      • 10.6.2 Global Ulcer Protective Drugs Price (2014-2019)

    11 Global Anti-Peptic Ulcer Drugs Market Segment by Application

    • 11.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Gastritis Sales Growth (2014-2019)
    • 11.3 Gastric Ulcers Sales Growth (2014-2019)
    • 11.4 Duodenal Ulcers Sales Growth (2014-2019)
    • 11.5 Gastroesophageal Reflux Disease (GERD) Sales Growth (2014-2019)

    12 Anti-Peptic Ulcer Drugs Market Forecast (2019-2024)

    • 12.1 Global Anti-Peptic Ulcer Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Anti-Peptic Ulcer Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Anti-Peptic Ulcer Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Anti-Peptic Ulcer Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Anti-Peptic Ulcer Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Anti-Peptic Ulcer Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Anti-Peptic Ulcer Drugs Market Forecast (2019-2024)
    • 12.3 Anti-Peptic Ulcer Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Anti-Peptic Ulcer Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Anti-Peptic Ulcer Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Anti-Peptic Ulcer Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Anti-Peptic Ulcer Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Anti-Peptic Ulcer Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Anti-Peptic Ulcer Drugs . Industry analysis & Market Report on Anti-Peptic Ulcer Drugs is a syndicated market report, published as Global Anti-Peptic Ulcer Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Anti-Peptic Ulcer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,683.08
      		4,024.62
      		5,366.16
      		3,222.48
      		4,833.72
      		6,444.96
      		533,275.20
      		799,912.80
      		1,066,550.40
      		293,468.40
      		440,202.60
      		586,936.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo